We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
-0.29%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$49B
AUM Growth
+$3.53B
(+7.8%)
Cap. Flow
+$4.13B
Cap. Flow
% of AUM
8.42%
Top 10 Holdings %
Top 10 Hldgs %
10.78%
Holding
2,899
New
681
Increased
729
Reduced
681
Closed
701
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$365M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$297M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$290M |
| 5 |
Applied Materials
AMAT
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$290M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Johnson Controls International
JCI
|
+$275M |
| 4 |
L3Harris
LHX
|
+$235M |
| 5 |
Visa
V
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.53% |
| 2 | Industrials | 11.09% |
| 3 | Healthcare | 8.52% |
| 4 | Consumer Discretionary | 7.23% |
| 5 | Financials | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Charles River Laboratories
CRL
$13.4B
| $13.6M | 0.03% |
69,584
+42,594
| +158% | +$8.74M |
|
702
Evolent Health
EVH
$458M
| $13.6M | 0.03% |
500,583
+133,380
| +36% | +$3.71M |
|
|
SLNO
703
DELISTED
Soleno Therapeutics
SLNO
| $13.5M | 0.03% |
+458,823
| New | +$2.78M |
|
704
United Parks & Resorts
PRKS
$2B
| $13.5M | 0.03% |
291,385
+200,305
| +220% | +$10.2M |
|
705
Essential Properties Realty Trust
EPRT
$6.52B
| $13.5M | 0.03% |
621,917
+612,088
| +6,227% | +$14.6M |
|
706
PUT
Immunovant
IMVT
$8.33B
| $13.4M | 0.03% |
+350,000
| New | +$7.91M |
|
707
PUT
Insmed
INSM
$28.9B
| $13.4M | 0.03% |
+532,000
| New | +$12.2M |
|
708
PUT
Oracle
ORCL
$419B
| $13.4M | 0.03% |
126,800
+26,800
| +27% | +$3.1M |
|
|
BRSP
709
BrightSpire Capital
BRSP
$628M
| $13.4M | 0.03% |
2,141,176
+266,798
| +14% | +$1.83M |
|
710
MoonLake Immunotherapeutics
MLTX
$1.4B
| $13.4M | 0.03% |
234,250
+164,909
| +238% | +$9.1M |
|
711
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $13.4M | 0.03% |
182,849
+176,260
| +2,675% | +$14.1M |
|
712
Knight Transportation
KNX
$11.2B
| $13.3M | 0.03% |
266,042
-890,575
| -77% | -$49.4M |
|
713
Box
BOX
$4.56B
| $13.3M | 0.03% |
550,321
+383,122
| +229% | +$10.9M |
|
714
Webster Financial
WBS
$12.8B
| $13.2M | 0.03% |
+326,942
| New | +$13.9M |
|
|
KREF
715
KKR Real Estate Finance Trust
KREF
$488M
| $13.2M | 0.03% |
1,109,546
-213,679
| -16% | -$2.63M |
|
|
GAP
716
The Gap Inc
GAP
$7.56B
| $13.2M | 0.03% |
+1,238,618
| New | +$12.6M |
|
717
Hayward Holdings
HAYW
$3.31B
| $13.2M | 0.03% |
+933,714
| New | +$12.8M |
|
718
CALL
Lam Research
LRCX
$390B
| $13.2M | 0.03% |
210,000
+110,000
| +110% | +$7.23M |
|
719
Landstar System
LSTR
$6.02B
| $13.2M | 0.03% |
+74,360
| New | +$14.3M |
|
720
CALL
Kenvue
KVUE
$36.5B
| $13.1M | 0.03% |
+653,900
| New | +$15.1M |
|
721
Goosehead Insurance
GSHD
$2.33B
| $13M | 0.03% |
175,016
-157,995
| -47% | -$10.6M |
|
|
ICPT
722
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $13M | 0.03% |
+702,900
| New | +$7.95M |
|
723
CALL
Dick's Sporting Goods
DKS
$18.4B
| $13M | 0.03% |
+120,000
| New | +$15.2M |
|
724
Bumble
BMBL
$366M
| $13M | 0.03% |
+873,208
| New | +$14.8M |
|
725
Regenxbio
RGNX
$700M
| $13M | 0.03% |
787,623
+238,677
| +43% | +$4.33M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Balyasny Asset Management held 2,899 positions worth $49B, up 7.8% from $45.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Balyasny Asset Management deployed $4.13B of net new capital in Q3 2023, opening 681 new positions and adding to 729 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was McDonald's, an estimated $290M trimmed.
- Balyasny Asset Management's largest Q3 2023 buy was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.
- Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $365M increase.
- Balyasny Asset Management's biggest Q3 2023 reduction was McDonald's, cutting an estimated $290M.
- Balyasny Asset Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $165M.
- Balyasny Asset Management's ten largest holdings make up 11% of its $49B portfolio in Q3 2023.
- Balyasny Asset Management opened 681 new positions and closed 701 in Q3 2023.
- Balyasny Asset Management's portfolio value rose 7.8% quarter-over-quarter to $49B.
Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.